Synedgen

Synedgen is a biopharmaceutical company dedicated to developing new therapies and products to reduce infections and inflammation on skin, oral, mucosal, and ocular surfaces. The company is currently leveraging its proprietary glycomics technology platform to develop glycopolymer-based therapeutic agents for infectious and inflammatory diseases.